3.84 USD
▲-0.33+1.32%
盘后 3.86 +1.85%
2026-08-03
市值
$1.37B
市盈率
—
EPS
-0.28
股息率
—
52 周区间
2.94 – 9.25
成交量
570.66K
Beta
0.19
目标价
5.75
52W 低 2.9452W 高 9.25
价格走势
公司简介
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company provides AVT02, a high concentration, low-volume adalimumab formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ankylosing spondylitis ulcerative colitis, and other indications; AVT04, a biosimilar to Stelara to treat variou...